Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study
Florence DalencDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceLuigi IulianoDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyThomas FilleronDepartment of Biostatistics, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceChiara ZerbinatiDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyMaud VoisinDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceCécile ArellanoInstitut Claudius-Regaud, IUCT-Oncopole and EA4553 University of Toulouse III Paul-Sabatier, Toulouse, FranceÉtienne ChatelutInstitut Claudius-Regaud, IUCT-Oncopole and EA4553 University of Toulouse III Paul-Sabatier, Toulouse, FrancePierre MarquetCHU Limoges, University of Limoges, U850 INSERM, Limoges, FranceMohammad SamadiLCPMC-A2, ICPM, Département de Chimie, University of Lorraine, Metz, FranceHenri RochéDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceMarc PoirotInserm UMR 1037, Team “Cholesterol metabolism and therapeutic innovations”, Cancer Research Center of Toulouse, Toulouse, FranceSandrine Silvente‐PoirotInserm UMR 1037, Team “Cholesterol metabolism and therapeutic innovations”, Cancer Research Center of Toulouse, Toulouse, France
2016en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0